PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 181 filers reported holding PTC THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.85 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $622 | -35.5% | 27,976 | +16.6% | 0.00% | -50.0% |
Q2 2023 | $964 | -16.8% | 24,000 | 0.0% | 0.00% | -33.3% |
Q1 2023 | $1,158 | +31.4% | 24,000 | 0.0% | 0.00% | +50.0% |
Q4 2022 | $881 | -99.9% | 24,000 | 0.0% | 0.00% | -50.0% |
Q3 2022 | $1,198,000 | +79.6% | 24,000 | +42.9% | 0.00% | +100.0% |
Q2 2022 | $667,000 | +6.4% | 16,800 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $627,000 | +2.1% | 16,800 | +9.8% | 0.00% | +100.0% |
Q4 2021 | $614,000 | +11.8% | 15,300 | +2.7% | 0.00% | -50.0% |
Q3 2021 | $549,000 | -11.2% | 14,900 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $618,000 | -10.4% | 14,900 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $690,000 | -50.7% | 14,900 | -32.0% | 0.00% | -60.0% |
Q4 2020 | $1,401,000 | -45.4% | 21,900 | -60.2% | 0.01% | -54.5% |
Q3 2020 | $2,567,000 | – | 55,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AXON CAPITAL LP | 216,200 | $9,729,000 | 20.31% |
GREAT POINT PARTNERS LLC | 1,974,385 | $88,847,000,000 | 9.86% |
RTW INVESTMENTS, LP | 3,137,361 | $141,181,000 | 7.54% |
Asymmetry Capital Management, L.P. | 280,542 | $12,624,000 | 6.84% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 259,000 | $11,642,000 | 4.32% |
Boxer Capital, LLC | 1,000,000 | $45,000,000 | 3.87% |
Opaleye Management Inc. | 226,388 | $10,187,000 | 3.10% |
SECTORAL ASSET MANAGEMENT INC | 450,638 | $20,279,000 | 2.42% |
SCOPIA CAPITAL MANAGEMENT LP | 983,005 | $44,235,000 | 1.96% |
Chubb Ltd | 8,180 | $368,000 | 1.82% |